Making sense of antisense oligonucleotide technology for FSHD
May 11, 2022•1 hr 41 min•Season 1Ep. 22
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
"They've done studies you know -- 60% of the time it works all the time."... "That doesn't make any sense." We discuss the different types of antisense oligonucleotide (AON/ASO) technologies and how these can be used therapeutically for FSHD.
For the best experience, listen in Metacast app for iOS or Android